Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY
This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult individuals of ≥18 years old.
• Willing to comply with the requirements of the protocol and available for follow-up for the planned duration of the trial.
• Has understood the information provided and capable of giving informed consent.
Locations
Other Locations
Spain
Germans Trias i Pujol Hospital
RECRUITING
Badalona
BCN Checkpoint
RECRUITING
Barcelona
VALLE HEBRÓN HOSPITAL/Centro Salud Internacional y Enfermedades Transmisibles Drassanes
NOT_YET_RECRUITING
Barcelona
Contact Information
Primary
Beatriz Mothe, PhD, MD
bmothe@irsicaixa.es
676142408
Backup
Susana Benet, PhD, MD
sbenet@lluita.org
676142408
Time Frame
Start Date: 2022-09-14
Estimated Completion Date: 2026-08
Participants
Target number of participants: 100
Treatments
MKP vaccination for pre-exposure prophylaxis (HIV positive)
HIV positive individuals who receive MKP vaccination for pre-exposure prophylaxis
MKP vaccination for pre-exposure prophylaxis (seronegative individuals)
HIV seronegative individuals who receive MKP vaccination for pre-exposure prophylaxis
Sponsors
Collaborators: BCN Checkpoint, IrsiCaixa
Leads: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia